The general manager of Iberma discusses the history of the Moroccan pharmaceutical industry, new measures to improve access, and working on…

The general manager of Servier Morocco reviews the situation of the market following the recent price cuts, how the local environment is changing with…

The president and chairman of MC Pharma discusses the position of the pharmacy segment in the current Moroccan healthcare context.  Could you…

The country manager of Pfizer Morocco talks about the likelihood of Morocco becoming an African hub and why Pfizer is at the perfect size to play a…

At Valeant each region has a unique mix of prescription brands, branded generics and OTC products. The general manager for Mexico, Central America,…

Daniel Varde, Deloitte’s top consultant for the healthcare and life sciences sector in Latin America, discusses the interaction of global, Latin…

The global COO of the multinational at the forefront of the fight against diabetes explains why the Algerian market is so strategically important and…

Oh Pil-Soo, managing director of Lundbeck Korea, talks about the challenges of pricing and reimbursement in the CNS area and remaining committed to…

 Miriam Martinez, CEO of Laboratorios Duncan and VP of CAPGEN, discusses the challenges her company faces as a generic manufacturer in a branded…

Brian Gladsden was appointed president of Novartis Korea in January 2014. He relates his previous experience to the market situation in Korea and…

Rhenu Bhuller provides insight into Malaysia’s healthcare industry positioning in the Southeast Asian region and the ability to provide affordable…

Cho Chan-Hwui, president of the Korean Pharmaceutical Association (KPA), discusses the major hurdles that pharmacists in Korea must overcome today,…